Monitor future Form 4 filings for any insider transactions by Brailer, which would signal his view of the stock. No immediate trading signal from this initial filing.
TEVA drugs
TEVA drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 13 $44.50entry
- T+1 · 16h ago −4.34%α −2.43% · $42.57
- T+5 · in 3d Pending
- T+20 · in 27d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
David J. Brailer filed a Form 3 initial statement of beneficial ownership upon becoming a non-executive director of Teva Pharmaceutical Industries. The filing includes a power of attorney authorizing officers to handle Section 16 reporting. No securities ownership amounts are disclosed in the filing.
Key Facts
- David J. Brailer appointed as non-executive director of Teva Pharmaceutical Industries Ltd.
- Form 3 filed on 2026-11-12 for period beginning 2026-11-03.
- Power of attorney executed on 2026-10-26 authorizing Dov Bergwerk, Shira Aran-Porat, and Matan Kimchi to handle Section 16 filings.
- No beneficial ownership amounts reported in the filing documents.
Financial Impact
No financial impact; routine director onboarding filing.
Risk Factors
- No ownership data disclosed; cannot assess insider alignment.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001193125-26-458294 |
| Document: 0001193125-26-458294-index-headers.html | 0001193125-26-458294 |
| Document: 0001193125-26-458294-index.html | 0001193125-26-458294 |
| Document: 0001193125-26-458294.txt | 0001193125-26-458294 |
Track record
61 reports on TEVA
6 of 8 bullish or bearish reports moved the stock their way by T+60. Best: +33.06% at T+60 after the Jul 20, 2026 report. 15 of 17 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $43.16 Now $42.57 −1.37% settles Feb 12
- Nov 12, 20264d ago 3 Neutral 2/10 Viewing Entry $44.50 Now $42.57 −4.34% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $44.50 Now $42.57 −4.34% settles Feb 11
- Nov 12, 20264d ago 144 Neutral 2/10 Entry $43.65 Now $42.57 −2.47% settles Feb 10
- Nov 10, 20266d ago 144 Neutral 3/10 Entry $43.24 Now $42.57 −1.55% settles Feb 9
- Nov 10, 20266d ago SC 13G/A Neutral 3/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $42.40 Now $42.57 +0.40% settles Feb 8
- Nov 6, 202610d ago Insider Cluster Neutral 3/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
- Nov 6, 202610d ago Insider Cluster Neutral 2/10 Entry $42.97 Now $42.57 −0.93% settles Feb 5
- Nov 5, 202611d ago 144 Neutral 2/10 Entry $42.61 Now $42.57 −0.09% settles Feb 4
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers